Phase I trial evaluating the safety and immunogenicity of candidate TB vaccine MVA85A, delivered by aerosol to healthy M.tb-infected adults

Phase I trial evaluating the safety and immunogenicity of candidate TB vaccine MVA85A, delivered by aerosol to healthy M.tb-infected adults

The immunogenicity of the candidate tuberculosis (TB) vaccine MVA85A may be enhanced by aerosol delivery. Intradermal administration was shown to be safe in adults with latent TB infection (LTBI), but data are lacking for aerosol-delivered candidate TB vaccines in this population. We carried out a P...

書誌詳細
主要な著者:	Riste, M, Marshall, JL, Satti, I, Harris, SA, Wilkie, M, Lopez Ramon, R, Wright, D, Wittenberg, RE, Vermaak, S, Powell Doherty, R, Lawrie, A, Conlon, CP, Cosgrove, C, Gleeson, F, Lipman, M, Moss, P, Perrin, F, Dedicoat, M, Bettinson, H, McShane, H
フォーマット:	Journal article
言語:	English
出版事項:	MDPI 2021

類似資料

Phase I Trial Evaluating the Safety and Immunogenicity of Candidate TB Vaccine MVA85A, Delivered by Aerosol to Healthy <em>M.tb</em>-Infected Adults
著者:: Michael Riste, 等
出版事項: (2021-04-01)

Evaluating aerosol administration of a candidate TB vaccine MVA85A
著者:: Thomas, Z, 等
出版事項: (2014)

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses.
著者:: Tameris, M, 等
出版事項: (2014)

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses
著者:: Tameris, M, 等
出版事項: (2014)

DEVELOPING A NEW TB VACCINE: BOOSTING BCG WITH MVA85A
著者:: Mcshane, H
出版事項: (2008)

Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: A phase I randomised controlled trial
著者:: Manjaly Thomas, Z, 等
出版事項: (2019)

A review of the tolerability of the candidate TB vaccine, MVA85A compared with BCG and Yellow Fever vaccines, and correlation between MVA85A vaccine reactogenicity and cellular immunogenicity
著者:: Rowland, R, 等
出版事項: (2012)

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses.
著者:: Michele Tameris, 等
出版事項: (2014-01-01)

Comparison of the safety and immunogenicity of a candidate TB vaccine, MVA85A, given by the intramuscular or intradermal route in BCG-vaccinated adults
著者:: Harris, S, 等
出版事項: (2011)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery.
著者:: Meyer, J, 等
出版事項: (2013)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery
著者:: Meyer, J, 等
出版事項: (2013)

Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: A phase I randomised controlled trial.
著者:: Zita-Rose Manjaly Thomas, 等
出版事項: (2019-04-01)

The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial.
著者:: Anne Wajja, 等
出版事項: (2017-05-01)

The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial
著者:: Wajja, A, 等
出版事項: (2017)

Phase I/II clinical trial of MVA85A in individuals with latent tuberculosis: The first subunit TB vaccine in clinical trial
著者:: Sander, C, 等
出版事項: (2005)

A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults
著者:: Minassian, A, 等
出版事項: (2011)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate TB vaccine, MVA85A, alone and in combination
著者:: Harris, S, 等
出版事項: (2013)

A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants
著者:: Odutola, A, 等
出版事項: (2012)

A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants.
著者:: Odutola, A, 等
出版事項: (2012)

Two doses of candidate TB vaccine MVA85A in antiretroviral therapy (ART) naive subjects gives comparable immunogenicity to one dose in ART+ subjects
著者:: Dieye, T, 等
出版事項: (2013)

A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime - MVA85A boost in healthy UK adults
著者:: Wilkie, M, 等
出版事項: (2019)

Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A.
著者:: Whelan, K, 等
出版事項: (2009)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults.
著者:: Pathan, A, 等
出版事項: (2012)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults
著者:: Pathan, A, 等
出版事項: (2012)

Differential cytokine levels in adults induced by a Novel candidate TB boost vaccine, MVA85A-according to previous BCG vaccination status
著者:: Owiafe, P, 等
出版事項: (2012)

Two doses of candidate TB vaccine MVA85A in antiretroviral therapy (ART) naïve subjects gives comparable immunogenicity to one dose in ART+ subjects.
著者:: Tandakha N Dieye, 等
出版事項: (2013-01-01)

Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A.
著者:: Kathryn T. Whelan, 等
出版事項: (2011-01-01)

TB vaccine development: where are we and why is it so difficult?
著者:: Wilkie, M, 等
出版事項: (2014)

Correction: Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naïve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects.
著者:: Tandakha N. Dieye, 等
出版事項: (2013-01-01)

A first-in-human phase 1 trial to evaluate the safety and immunogenicity of the candidate tuberculosis vaccine MVA85A-IMX313, administered to BCG-vaccinated adults.
著者:: Minhinnick, A, 等
出版事項: (2016)

Diagnosis of extrapulmonary TB: Experience with the Xpert MTB/Rif assay
著者:: C.N. Govind, 等
出版事項: (2014-04-01)

Evaluation of Xpert MTB/RIF assay for the diagnosis of paediatric TB
著者:: F. Ismail, 等
出版事項: (2014-04-01)

Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
出版事項: (2011-01-01)

Diagnostic performance of GeneXpert MTB/RIF in detecting MTB in smear-negative presumptive TB patients
著者:: Raksha Rimal, 等
出版事項: (2022-04-01)

Impact of introduction of Xpert MTB/RIF test on tuberculosis (TB) diagnosis in a city with high TB incidence in Brazil.
著者:: Giovana Rodrigues Pereira, 等
出版事項: (2018-01-01)

Enhancing TB case detection: experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB.
著者:: Neeraj Raizada, 等
出版事項: (2014-01-01)

Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic review
著者:: Mcshane, H, 等
出版事項: (2016)

TB or not TB?
著者:: Andrew Pirotte, 等
出版事項: (2024-04-01)

Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial.
著者:: Satti, I, 等
出版事項: (2014)

Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: A phase 1, double-blind, randomised controlled trial
著者:: Satti, I, 等
出版事項: (2014)